Page last updated: 2024-11-05

2,2,4-trimethylpentane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2,4-trimethylpentane: nephrotoxic [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

isooctane : An alkane that consists of pentane bearing two methyl substituents at position 2 and a single methyl substituent at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10907
CHEMBL ID1797261
CHEBI ID62805
MeSH IDM0132991

Synonyms (75)

Synonym
nsc39117
pentane,2,4-trimethyl-
isobutyltrimethylmethane
isooctane
wln: 1y1&1x1&1&1
nsc-39117
2,4,4-trimethylpentane
einecs 208-759-1
brn 1696876
nsc 39117
hsdb 5682
ai3-23976
inchi=1/c8h18/c1-7(2)6-8(3,4)5/h7h,6h2,1-5h
pentane, 2,2,4-trimethyl-
2,2,4-trimethylpentane
540-84-1
2,2,4-trimethylpentane, acs spectrophotometric grade, >=99%
2,2,4-trimethylpentane, anhydrous, 99.8%
I0276
T0715
T0481
NCGC00248930-01
AKOS009159117
CHEMBL1797261
(ch3)2chch2c(ch3)3
CHEBI:62805 ,
iso-octane
NCGC00258679-01
tox21_201127
dtxcid104370
cas-540-84-1
dtxsid7024370 ,
STL280330
ec 208-759-1
unii-qab8f5669o
4-01-00-00439 (beilstein handbook reference)
qab8f5669o ,
FT-0609110
iso-octane [hsdb]
isooctane [mi]
isooctane [inci]
isobutyltrimethylethane
2,2,4-trimethyl pentane
i-octane
W-109087
2,2,4-trimethylpentane, environmental grade
2,2,4-trimethylpentane, hplc grade
mfcd00008943
2,2,4-trimethylpentane, reagentplus(r), >=99%
2,2,4-trimethylpentane, hplc grade, >=99.7%
2,2,4-trimethylpentane, puriss. p.a., acs reagent, >=99.5% (gc)
2,2,4-trimethylpentane, saj first grade, >=98.0%
density standard 692 kg/m3, h&d fitzgerald ltd. quality
2,2,4-trimethylpentane, analytical standard
2,2,4-trimethylpentane, puriss. p.a., >=99.5% (gc)
2,2,4-trimethylpentane, jis special grade
2,2,4-trimethylpentane, >=99.5%, suitable for absorption spectrum analysis
2,2,4-trimethylpentane, for hplc, >=99%
2,2,4-trimethylpentane, for hplc
2,2,4-trimethylpentane, acs reagent, >=99.0%
2,2,4-trimethylpentane, acs, 99+%
2,2,4-trimethylpentane, puriss. p.a., acs reagent
2,2,4-trimethylpentane, astm, 99.8%
2,2,4-trimethylpentane, lr, >=99%
2,2,4-trimethylpentane, p.a., 99.5%
2,2,4-trimethylpentane, acs reagent, 99.5%
2,2,4-trimethylpentane (isooctane), pharmaceutical secondary standard; certified reference material
2,2,4-trimethylpentane, ar, >=99.5%
2,2,4-trimethylpentane, for hplc, >=99.8%
2,2,4-trimethylpentane, uv hplc spectroscopic, 99.5%
2,2,4-trimethylpentane, pesticide, 99.5%
trimethyl-2,2,4 pentane
Q209130
2,2,4-trimethyl-pentane
isooctane blank

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" To estimate in vivo metabolic kinetics of TMP and to predict its target tissue dosimetry during inhalation exposures, a physiologically based pharmacokinetic (PBPK) model was developed for the chemical in Long-Evans male rats using closed-chamber gas-uptake experiments."( Development of an inhalation physiologically based pharmacokinetic (PBPK) model for 2,2, 4-trimethylpentane (TMP) in male Long-Evans rats using gas uptake experiments.
Dowd, S; El-Masri, HA; Evans, M; Harrison, R; Pegram, RA; Simmons, JE; Yavanhxay, SJ, 2009
)
0.35

Bioavailability

ExcerptReferenceRelevance
" In spite of lower imprinting factor, the relative bioavailability of the gastro-floating LC-MIP was 180."( Solvent-responsive floating liquid crystalline-molecularly imprinted polymers for gastroretentive controlled drug release system.
Chen, M; Huang, YP; Liu, ZS; Pang, QQ; Tang, L; Wang, XL; Zhang, LP, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" H4IIE cells were dosed with three micrograms of UL-14C-PCB77/plate dissolved in DMSO or isooctane, and were harvested at sequential time periods for 4 days."( Carrier effects of dosing the H4IIE cells with 3,3',4,4'-tetrachlorobiphenyl (PCB77) in dimethyl sulfoxide or isooctane.
Burton, GA; Fisher, JW; Tillitt, DE; Yu, KO, 1997
)
0.3
" Relative kidney weights were increased in male rats dosed with DMMP, DEEP, and TMP."( Biotransformation and male rat-specific renal toxicity of diethyl ethyl- and dimethyl methylphosphonate.
Blumbach, K; Deger, HM; Dekant, W; Pähler, A, 2000
)
0.31
" The results showed that, before reaching a maximum, the increase of ferulic acid concentration, temperature, or enzyme dosage led to an increase in volumetric productivity."( Lipase-catalyzed esterification of ferulic Acid with oleyl alcohol in ionic liquid/isooctane binary systems.
Chen, B; Guo, Z; Huang, J; Liu, H; Wang, M; Xu, X; Zheng, L, 2011
)
0.37
"15 mol x L(-1) of KCl, dosage of n-butanol 2%."( [Study on the backward extraction of cellulase in rhamnolipid reverse micelles].
Cui, KL; Huang, HJ; Peng, X; Peng, ZY; Yuan, XZ; Zeng, GM; Zhao, YG, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
fuel additiveAny additive that enhances the efficiency of fuel.
non-polar solventnull
nephrotoxinA poison that interferes with the function of the kidneys.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
alkaneAn acyclic branched or unbranched hydrocarbon having the general formula CnH2n+2, and therefore consisting entirely of hydrogen atoms and saturated carbon atoms.
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency40.02660.006038.004119,952.5996AID1159521
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency59.98850.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency47.83040.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency56.53910.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency30.46440.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency56.91420.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (195)

TimeframeStudies, This Drug (%)All Drugs %
pre-199037 (18.97)18.7374
1990's46 (23.59)18.2507
2000's74 (37.95)29.6817
2010's35 (17.95)24.3611
2020's3 (1.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.65 (24.57)
Research Supply Index5.37 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index113.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (66.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.47%)6.00%
Case Studies1 (0.47%)4.05%
Observational0 (0.00%)0.25%
Other212 (99.07%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]